51
|
Stöckmann H, O'Flaherty R, Adamczyk B, Saldova R, Rudd PM. Automated, high-throughput serum glycoprofiling platform. Integr Biol (Camb) 2015; 7:1026-32. [PMID: 26189827 DOI: 10.1039/c5ib00130g] [Citation(s) in RCA: 45] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Complex carbohydrates are rapidly becoming excellent biomarker candidates because of their high sensitivity to pathological changes. However, the discovery of clinical glycobiomarkers has been slow, due to the scarcity of high-throughput glycoanalytical workflows that allow rapid glycoprofiling of large clinical sample sets. To generate high-quality quantitative glycomics data in a high-throughput fashion, we have developed a robotized platform for rapid serum-based N-glycan sample preparation. The sample preparation workflow features a fully automated, rapid glycoprotein denaturation followed by sequential enzymatic glycan release, glycan purification on solid-supported hydrazide and fluorescent labelling. This allows accurate glycan quantitation by ultra-high performance liquid chromatography (UPLC). The sample preparation workflow was automated using an eight-channel Hamilton Robotics liquid handling workstation, allowing the preparation of almost 100 samples in 14 hours with excellent reproducibility and thus should greatly facilitate serum-based glyco-biomarker discovery.
Collapse
Affiliation(s)
- H Stöckmann
- NIBRT GlycoScience Group, NIBRT - The National Institute for Bioprocessing Research and Training, Fosters Avenue, Mount Merrion, Blackrock, Co.Dublin, Ireland.
| | | | | | | | | |
Collapse
|
52
|
Sethi MK, Kim H, Park CK, Baker MS, Paik YK, Packer NH, Hancock WS, Fanayan S, Thaysen-Andersen M. In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation. Glycobiology 2015; 25:1064-78. [PMID: 26085185 DOI: 10.1093/glycob/cwv042] [Citation(s) in RCA: 69] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2015] [Accepted: 06/11/2015] [Indexed: 01/01/2023] Open
Abstract
Glycomics may assist in uncovering the structure-function relationships of protein glycosylation and identify glycoprotein markers in colorectal cancer (CRC) research. Herein, we performed label-free quantitative glycomics on a carbon-liquid chromatography-tandem mass spectrometry-based analytical platform to accurately profile the N-glycosylation changes associated with CRC malignancy. N-Glycome profiling was performed on isolated membrane proteomes of paired tumorigenic and adjacent non-tumorigenic colon tissues from a cohort of five males (62.6 ± 13.1 y.o.) suffering from colorectal adenocarcinoma. The CRC tissues were typed according to their epidermal growth factor receptor (EGFR) status by western blotting and immunohistochemistry. Detailed N-glycan characterization and relative quantitation identified an extensive structural heterogeneity with a total of 91 N-glycans. CRC-specific N-glycosylation phenotypes were observed including an overrepresentation of high mannose, hybrid and paucimannosidic type N-glycans and an under-representation of complex N-glycans (P < 0.05). Sialylation, in particular α2,6-sialylation, was significantly higher in CRC tumors relative to non-tumorigenic tissues, whereas α2,3-sialylation was down-regulated (P < 0.05). CRC stage-specific N-glycosylation was detected by high α2,3-sialylation and low bisecting β1,4-GlcNAcylation and Lewis-type fucosylation in mid-late relative to early stage CRC. Interestingly, a novel link between the EGFR status and the N-glycosylation was identified using hierarchical clustering of the N-glycome profiles. EGFR-specific N-glycan signatures included high bisecting β1,4-GlcNAcylation and low α2,3-sialylation (both P < 0.05) relative to EGFR-negative CRC tissues. This is the first study to correlate CRC stage and EGFR status with specific N-glycan features, thus advancing our understanding of the mechanisms causing the biomolecular deregulation associated with CRC.
Collapse
Affiliation(s)
| | - Hoguen Kim
- Department of Pathology, Yonsei University College of Medicine, Seoul 120-752, Korea
| | - Cheol Keun Park
- Department of Pathology, Yonsei University College of Medicine, Seoul 120-752, Korea
| | - Mark S Baker
- Department of Biomedical Sciences, Macquarie University, North Ryde NSW 2109, Australia
| | - Young-Ki Paik
- Yonsei Proteome Research Center, Yonsei University, Seoul 120-749, Korea
| | | | - William S Hancock
- Department of Biomedical Sciences, Macquarie University, North Ryde NSW 2109, Australia Barnett Institute and Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA 02115, USA
| | - Susan Fanayan
- Department of Biomedical Sciences, Macquarie University, North Ryde NSW 2109, Australia
| | | |
Collapse
|
53
|
Liang T, Fu Q, Shen A, Wang H, Jin Y, Xin H, Ke Y, Guo Z, Liang X. Preparation and chromatographic evaluation of a newly designed steviol glycoside modified-silica stationary phase in hydrophilic interaction liquid chromatography and reversed phase liquid chromatography. J Chromatogr A 2015; 1388:110-8. [DOI: 10.1016/j.chroma.2015.02.019] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2014] [Revised: 12/16/2014] [Accepted: 02/08/2015] [Indexed: 11/15/2022]
|
54
|
Abrahams JL, Packer NH, Campbell MP. Relative quantitation of multi-antennary N-glycan classes: combining PGC-LC-ESI-MS with exoglycosidase digestion. Analyst 2015; 140:5444-9. [DOI: 10.1039/c5an00691k] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
In the search for N-glycan disease biomarkers current glycoanalytical methods may not be revealing a complete picture of precious samples, and we may be missing valuable structural information that fall outside analysis windows.
Collapse
Affiliation(s)
- J. L. Abrahams
- Department of Chemistry and Biomolecular Sciences
- Macquarie University
- Sydney
- Australia
| | - N. H. Packer
- Department of Chemistry and Biomolecular Sciences
- Macquarie University
- Sydney
- Australia
| | - M. P. Campbell
- Department of Chemistry and Biomolecular Sciences
- Macquarie University
- Sydney
- Australia
| |
Collapse
|
55
|
Mahan AE, Tedesco J, Dionne K, Baruah K, Cheng HD, De Jager PL, Barouch DH, Suscovich T, Ackerman M, Crispin M, Alter G. A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis. J Immunol Methods 2014; 417:34-44. [PMID: 25523925 DOI: 10.1016/j.jim.2014.12.004] [Citation(s) in RCA: 78] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2014] [Revised: 12/08/2014] [Accepted: 12/09/2014] [Indexed: 02/02/2023]
Abstract
The N-glycan of the IgG constant region (Fc) plays a central role in tuning and directing multiple antibody functions in vivo, including antibody-dependent cellular cytotoxicity, complement deposition, and the regulation of inflammation, among others. However, traditional methods of N-glycan analysis, including HPLC and mass spectrometry, are technically challenging and ill suited to handle the large numbers of low concentration samples analyzed in clinical or animal studies of the N-glycosylation of polyclonal IgG. Here we describe a capillary electrophoresis-based technique to analyze plasma-derived polyclonal IgG-glycosylation quickly and accurately in a cost-effective, sensitive manner that is well suited for high-throughput analyses. Additionally, because a significant fraction of polyclonal IgG is glycosylated on both Fc and Fab domains, we developed an approach to separate and analyze domain-specific glycosylation in polyclonal human, rhesus and mouse IgGs. Overall, this protocol allows for the rapid, accurate, and sensitive analysis of Fc-specific IgG glycosylation, which is critical for population-level studies of how antibody glycosylation may vary in response to vaccination or infection, and across disease states ranging from autoimmunity to cancer in both clinical and animal studies.
Collapse
Affiliation(s)
- Alison E Mahan
- Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
| | | | - Kendall Dionne
- Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
| | - Kavitha Baruah
- Department of Biochemistry, Oxford University, Oxford, United Kingdom
| | - Hao D Cheng
- Thayer School of Engineering, Dartmouth College, Hanover, NH, United States
| | - Philip L De Jager
- Department of Neurology, Brigham and Women's Hospital, Boston, MA, United States
| | - Dan H Barouch
- Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, United States
| | - Todd Suscovich
- Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
| | - Margaret Ackerman
- Thayer School of Engineering, Dartmouth College, Hanover, NH, United States
| | - Max Crispin
- Department of Biochemistry, Oxford University, Oxford, United Kingdom
| | - Galit Alter
- Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States.
| |
Collapse
|
56
|
O'Regan NL, Steinfelder S, Schwedler C, Rao GB, Srikantam A, Blanchard V, Hartmann S. Filariasis asymptomatically infected donors have lower levels of disialylated IgG compared to endemic normals. Parasite Immunol 2014; 36:713-20. [DOI: 10.1111/pim.12137] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2014] [Accepted: 08/07/2014] [Indexed: 12/12/2022]
Affiliation(s)
- N. L. O'Regan
- Institute of Immunology; Center for Infection Medicine; Freie Universität Berlin; Berlin Germany
| | - S. Steinfelder
- Institute of Immunology; Center for Infection Medicine; Freie Universität Berlin; Berlin Germany
| | - C. Schwedler
- Clinical Chemistry and Pathobiochemistry; Institute of Laboratory Medicine; Charité Medical University; Berlin Germany
| | - G. B. Rao
- Blue Peter Public Health and Research Centre-LEPRA Society; Hyderabad Andhra Pradesh India
| | - A. Srikantam
- Blue Peter Public Health and Research Centre-LEPRA Society; Hyderabad Andhra Pradesh India
| | - V. Blanchard
- Clinical Chemistry and Pathobiochemistry; Institute of Laboratory Medicine; Charité Medical University; Berlin Germany
| | - S. Hartmann
- Institute of Immunology; Center for Infection Medicine; Freie Universität Berlin; Berlin Germany
| |
Collapse
|
57
|
Lauc G, Krištić J, Zoldoš V. Glycans - the third revolution in evolution. Front Genet 2014; 5:145. [PMID: 24904645 PMCID: PMC4033155 DOI: 10.3389/fgene.2014.00145] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2014] [Accepted: 05/04/2014] [Indexed: 11/13/2022] Open
Abstract
The development and maintenance of a complex organism composed of trillions of cells is an extremely complex task. At the molecular level every process requires a specific molecular structures to perform it, thus it is difficult to imagine how less than tenfold increase in the number of genes between simple bacteria and higher eukaryotes enabled this quantum leap in complexity. In this perspective article we present the hypothesis that the invention of glycans was the third revolution in evolution (the appearance of nucleic acids and proteins being the first two), which enabled the creation of novel molecular entities that do not require a direct genetic template. Contrary to proteins and nucleic acids, which are made from a direct DNA template, glycans are product of a complex biosynthetic pathway affected by hundreds of genetic and environmental factors. Therefore glycans enable adaptive response to environmental changes and, unlike other epiproteomic modifications, which act as off/on switches, glycosylation significantly contributes to protein structure and enables novel functions. The importance of glycosylation is evident from the fact that nearly all proteins invented after the appearance of multicellular life are composed of both polypeptide and glycan parts.
Collapse
Affiliation(s)
- Gordan Lauc
- Department of Biochemistry and Molecular Biology, Faculty of Pharmacy and Biochemistry, University of Zagreb Zagreb, Croatia ; Genos Glycoscience Zagreb, Croatia
| | | | - Vlatka Zoldoš
- Department of Molecular Biology, Faculty of Science, University of Zagreb Zagreb, Croatia
| |
Collapse
|